Therapeutics for type-2 diabetes mellitus: a glance at the recent inclusions and novel agents under development for use in clinical practice
Najeeb Shah(University of Hull), Thozhukat Sathyapalan(Hull York Medical School), Mohammed Abdalla(University of East Anglia), Harshal Deshmukh(University of Dundee)
Cited by 34
Related Papers
Global burden of 292 causes of death in 204 countries and territories and 660 subnational locations, 1990–2023: a systematic analysis for the Global Burden of Disease Study 2023
|The Lancet|2025|384
African Origins of the Domestic Donkey
|Science|2004|290
New Susceptibility Loci Associated with Kidney Disease in Type 1 Diabetes
|PLoS Genetics|2012|281
Pharmacogenetic meta-analysis of genome-wide association studies of LDL cholesterol response to statins
|Nature Communications|2014|281